Abstract
Catecholamines are compounds composed of a catechol nucleus (a benzene ring with two adjacent hydroxyl groups) and an amine-containing side-chain. The catecholamines occurring in man are dopamine, noradrenaline, and adrenaline. Dopamine serves as a neurotransmitter in the central nervous system. Furthermore, this amine functions as a precursor for noradrenaline and adrenaline. Noradrenaline is synthesized in the chromaffin tissue, in parts of the brain, and in the postganglionic sympathetic nerves, where it serves as the neurotransmitter substance. Adrenaline is synthesized in the brain and in the chromaffin cells. Most of the adrenaline is formed in the chromaffin cells of the adrenal medulla, from where it is secreted into the blood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blaustein MP: The role of calcium in catecholamine release from adrenergic nerve terminals. In: The Release of Catecholamines from Adrenergic Neurons, pp. 39–58. Paton DM, ed. Oxford: Pergamon, 1979.
Starke K, Taube HD, Borowski E: Presynaptic receptor systems in catecholaminergic transmission. Biochem Pharmacol 26: 259–268, 1977.
Stjärne L: Role of prostaglandins and cyclic adenosine monophate in release. In: The Release of Catecholamines from Adrenergic Neurons, pp. 111–142. Paton DM ed. Oxford: Pergamon, 1979.
Muscholl E: Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239: H713–H720, 1980.
von Euler US, Franksson C, Hellström J: Adrenaline and noradrenaline output in urine after unilateral and bilateral adrenalectomy in man. Acta Physiol Scand 31: 1–5, 1954.
Reid JL: Plasma noradrenaline as an index of sympathetic activity. In: Hypertension. Mechanisms and Management, pp. 65–71. Philipp T, Distler A, eds. Berlin: Springer-Verlag, 1980.
Whitby LG, Axelrod J, Weil-Malherbe H: The fate of H3-norepinephrine in animals. J Pharmacol Exp Ther 132: 193–201, 1961.
Wurtman RJ: Catecholamines. Boston: Little, Brown, 1966.
Kopin IJ: Storage and metabolism of catecholamines: the role of monoamine oxidase. Pharmacol Rev 16: 179–191, 1964.
Kopin IJ: Biochemical assessment of peripheral adrenergic activity. In: The release of catecholamines from adrenergic neurons, pp. 355–372. Paton DM, ed. Oxford: Pergamon, 1979.
Langer SZ, Massingham R, Shepperson NB: Presence of postsynaptic § 2-adrenoceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb. Clin Sci 59: 225s–228s, 1980.
Davis JO, Freeman RH: Mechanisms regulating renin release. Physiol Rev 56: 2–56, 1976.
Starke K: Action of angiotensin on uptake, release and metabolism of 14C-noradrenaline by isolated rabbit hearts. Eur J Pharmacol 14: 112–123, 1971.
Philipp T. Brokamp B, Cordes U, Lüth B, Distler A: Sympathikusaktivität und pressorische Wirkung von Noradrenalin bei Patienten mit hypo- und hyperthyreoter Stoffwechsellage. Verh Dtsch Ges Inn Med 85: 1047–1049, 1979.
Abboud FM, Heistad DD, Mark AL, et al.: Reflex control of the peripheral circulation. Prog Cardiovasc Dis 18: 371 - 403, 1976.
Robertson D, Shand DG, Hollifield JW, Nies AS, Frölich JC, Oates JA: Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension. Hypertension 1: 118–124, 1979.
DiCara LV, Miller NE: Instrumental learning of vasomotor responses by rats: learning to respond differentially in the two ears. Science 159: 1485–1486, 1968.
Engelman K, Portnoy B, Lovenberg W: A sensitive and specific double-isotope derivative method for the determination of catecholamines in biological specimens. Am J Med Sci 255: 259–268, 1968.
DaPrada M, Zürcher G: Simultaneous radio-enzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19: 1161–1174, 1976.
Peuler JD, Johnson GA: Simultaneous single isotope radioenzymatic assay of plasma nor-epinephrine, epinephrine and dopamine. Life Sci 21: 625–636, 1977.
Miura Y, Campese V, de Quattro V, Meijer D: Plasma catecholamines via an improved fluorimetric assay: comparison with an enzymatic method. J Lab Clin Med 89: 421–427, 1977.
Sever PS: Catecholamines in essential hypertension: The present controversy. In: Circulating Catecholamines and Blood Pressure, pp. 1–10. Birkenhäger WH, Falke HE, eds. Utrecht: Bunge Scientific, 1978.
Lake CR, Ziegler MG, Coleman MD, Kopin IJ: Age-adjusted plasma-norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208–209, 1977.
Pedersen EB, Christensen NJ: Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand 198: 373–377, 1975.
Sever PS, Osikowska B, Birch M, Tunbridge RDG: Plasma noradrenaline in essential hypertension. Lancet 1: 1078–1081, 1977.
De Champlain J, Cousineau D: Lack of correlation between age and circulating catecholamines in hypertensive patients. N Engl J Med 297: 672, 1977.
De Quattro V, Chan S: Raised plasma catecholamines in some patients with primary hyper-tension. Lancet 1: 806–809, 1972.
Wallin BG, Sundlöf G, Eriksson B-M, Dominiak P, Grobecker H, Lindblad LE: Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 111: 69–73, 1981.
De Champlain J, Farley L, Cousineau D, van Ameringen M-R: Circulating catecholamine levels in human and experimental hypertension. Circ Res 38: 109–114, 1976.
Lake CR, Ziegler MG, Kopin IJ: Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci 18: 1315–1326, 1976.
Vecht RJ, Gordon D, Sever P: Catecholamines, isometric exercise and left ventricular function. In: Hypertension. Mechanisms and Management, pp. 55–63. Philipp T, Distler A, eds. Berlin: Springer-Verlag, 1980.
Jones DH, Allison DJ, Hamilton CA, Reid JL: Selective venous sampling in the diagnosis and localization of phaeochromocytoma. Clin Endocrinol 10: 179–186, 1979.
De Champlain J: The contribution of the sympathetic nervous system to arterial hypertension. Canad J Physiol Pharmacol 56: 341–353, 1978.
Haefely W, Hiirlimann A, Thoenen H: Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat. J Physiol 181: 48–58, 1965.
Yamaguchi N, de Champlain J, Nadeau R: Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circulat Res 36: 662–667, 1975.
Irving MH, Britton BJ, Wood WG, Padgham C, Carruthers M: Effects of ß-adrenergic blockade on plasma catecholamines in exercise. Nature (London) 248: 531–533, 1974.
Distler A, Keim HJ, Cordes U, Philipp T, Wolff HP: Sympathetic responsiveness and anti-hypertensive effect of beta-receptor blockade in essential hypertension. Am J Med 64: 446–451, 1978.
de Leeuw PW, Wester A, Willemse PJ, Birkenhäger WH: Patterns of noradrenaline and renin in essential hypertension - effects of stress and therapy. In: Hypertension. Mechanisms and Management, pp. 49–54. Philipp T, Distler A, eds. Berlin: Springer-Verlag, 1980.
Romoff MS, Keusch G, Campese VM, Wang M-S, Friedler RM, Weidmann P, Massry SG: Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metabol 48: 26–31, 1978.
Bannister R, Sever PS, Gross M: Cardiovascular reflexes and biochemical responses in progressive autonomic failure. Brain: 100: 324–344, 1977.
Louis WJ, Doyle AE, Anavekar SH: Plasma norepinephrine levels in essential hypertension. N Engl J Med 288: 599–601, 1973.
Brecht HM, Schoeppe W: Relation of plasma noradrenaline to blood pressure, age, sex and sodium balance in patients with essential hypertension and in normotensive subjects. Clin Sci mol Med 55: 81s–83s, 1978.
Bertel O, Bühler FR, Kiowski W, Liitold BE: Decreased beta-adrenoceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 2: 130–138, 1980.
Philipp T, Cordes U, Distler A: Sympathetic nervous system and blood pressure control in essential hypertension. Lancet ii: 959–963, 1978.
Le Blanc J, Côté J, Jobin M, Labrie A: Plasma catecholamines and cardiovascular responses to cold and mental activity. J Appl Physiol 47: 1207–1211, 1979.
Weidmann P, Beretta-Piccoli C, Ziegler WH, Keusch G, Glück Z, Reubi FC: Age versus urinary sodium forjudging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int 14: 619–628, 1978.
Engelman K, Portnoy B, Sjoerdsma A: Plasma catecholamine concentrations in patients with essential hypertension. Circ Res 26 and 27 (Suppl. I): 141–145, 1970.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Distler, A. (1982). Role of Catecholamines in Blood Pressure Regulation. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-7476-0_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7478-4
Online ISBN: 978-94-009-7476-0
eBook Packages: Springer Book Archive